CIAM
CTMX icon

Caitong International Asset Management’s CytomX Therapeutics CTMX Stock Holding History

Caitong International Asset Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.2K Buy
11,794
+10,145
+615% +$38.7K 0.01% 752
2026
Q1 		$7.75K Sell
1,649
-3,041
-65% -$15.4K ﹤0.01% 1102
2025
Q4 		$20K Buy
4,690
+4,001
+581% +$15.2K ﹤0.01% 984
2025
Q3 		$2.2K Sell
689
-967
-58% -$2.18K ﹤0.01% 1368
2025
Q2 		$3.76K Buy
+1,656
New +$2.67K ﹤0.01% 1137

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Caitong International Asset Management's CTMX Position: Q2 2026 in Review

Caitong International Asset Management increased its CytomX Therapeutics (CTMX) stake by 615% in Q2 2026, buying an estimated $38.7K and bringing the position to 11,794 shares worth $44.2K. The position accounts for 0.01% of the portfolio, ranked #752.

Caitong International Asset Management first reported a position in CTMX in Q2 2025 and has held it in 5 quarters since. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Caitong International Asset Management held 11,794 shares of CytomX Therapeutics worth $44.2K as of Q2 2026.
  • Caitong International Asset Management bought 10,145 CytomX Therapeutics shares in Q2 2026, an estimated $38.7K.
  • CytomX Therapeutics made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #752 holding.
  • Caitong International Asset Management first reported a position in CytomX Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.